Phospholipidation of HDL-how much is too much?

Clinical Chemistry

Volumn 57, Issue 1, 2011, Pages 4-6

  Lagor, William R ^a   Rader, Daniel J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; AUTOANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATABOLISM; CHOLESTEROL BLOOD LEVEL; HYPERLIPIDEMIA; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN SECRETION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; GENETIC VARIATION; HUMANS; LIPOPROTEINS, HDL; MICE; MICE, KNOCKOUT; PHOSPHOLIPID TRANSFER PROTEINS; RISK FACTORS;

EID: 78650993127     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.156224     Document Type: Review

References (5)

1. Tzotzas T, Desrumaux C, Lagrost L. Plasma phospholipid transfer protein (PLTP): Review of an emerging cardiometabolic risk factor. Obes Rev 2009;10:403-11.
2. Jiang XC. The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis. Front Biosci 2002;7:d1634-41.
3. Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, et al. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Circulation 2010;122: 470-7.
4. Jarvik GP, Rajagopalan R, Rosenthal EA, Wolfbauer G, McKinstry L, Vaze A, et al. Genetic and nongenetic sources of variation in phospholipid transfer protein activity. J Lipid Res 2010;51: 983-90.
5. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466: 707-13.